SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-235189
Filing Date
2022-08-31
Accepted
2022-08-31 16:01:08
Documents
12
Period of Report
2022-08-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d383713d8k.htm   iXBRL 8-K 30140
  Complete submission text file 0001193125-22-235189.txt   155094

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vinc-20220831.xsd EX-101.SCH 2845
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20220831_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20220831_pre.xml EX-101.PRE 11700
6 EXTRACTED XBRL INSTANCE DOCUMENT d383713d8k_htm.xml XML 3468
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 221217969
SIC: 2834 Pharmaceutical Preparations